Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Vorinostat × 1 year × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Brain Neoplasms 3 Recurrence 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Glioblastoma 2 Breast Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Ototoxicity 1 Oligodendroglioma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1

Interventions

Vemurafenib 4 selpercatinib 3 Magnetic Resonance Spectroscopy 3 trametinib 2 entrectinib 2 dabrafenib 2 cobimetinib 2 X-Rays 2 Specimen Handling 2 tremelimumab 1 tovorafenib 1 spartalizumab 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 copanlisib 1 cabozantinib 1 Whole Body Imaging 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Sunitinib 1 Robotic Surgical Procedures 1 Radiofrequency Ablation 1 Postoperative Period 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Mitoxantrone 1 Iodine-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡